Orgenesis Inc. ORGS
Set alert
0.03 USD -0.02 -39.94%
At close · Oct 30
0.91 Day range 0.91
0.0001 52-week range 0.91
- YTD
- -81.30%
- 1 year
- -81.30%
- Open
- 0.91
- Prev close
- 0.0467
- Mkt cap
- 274.88K
- Vol
- 100
- Avg vol
- 1.09K
- EPS
- -1.34
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.91
- High
- 0.91
- Forward P/E
- 1.97
- Beta
- 1.32
- Short ratio
- 2.39
- Inst. own
- 4.39%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.62
- 200-d avg
- 5.45
- 1y target
- 0.00
3M chart
Signals (43)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 2 months ago |
Key statistics
- Market cap
- 5.72M
- Enterprise value
- 17.86M
- Trailing P/E
- 0.00
- Forward P/E
- 1.97
- PEG ratio
- 0.00
- Price / sales
- 8.65
- Price / book
- 0.00
- EPS (TTM)
- -8.00
- Beta
- 1.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 662.00K
- Revenue growth
- 117.70%
- Free cash flow
- 9.71M
- Total cash
- 77.00K
- Total debt
- 13.02M
- Return on equity
- 0.00%
- Shares outstanding
- 4.77M
- Short % of float
- 1.33%
- 50-day average
- 3.62
- 200-day average
- 5.45
Analyst view
Consensus: buy
Buy
Price target (mean) 0.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
ORGS Revenue — quarterly 246.00K
ORGS Net income — quarterly -8.90M
ORGS EPS — quarterly 2.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -1.93 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -2.30 | — | — |
| May 21, 2024 | Mar 1, 2024 | 0.00 | -2.90 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -4.30 | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -1.50 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 13, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Mar 21, 2023 | Benchmark | reit | — | Buy |
| Sep 25, 2019 | Benchmark | init | — | Speculative Buy |
About Orgenesis Inc.
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- orgenesis.com
News
- Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket
- Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
- Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Tuesday
- Stocks That Hit 52-Week Lows On Thursday
Your note
Sign in to keep a note on ORGS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MILLER VICTOR | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 31, 2024 | 25,000 |
| SAFIER JACOB | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 31, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 5.92% | 924,806 | 1.29M | Jun 29, 2023 |
| Knoll Capital Management, LLC | 4.06% | 634,738 | 882.28K | Jun 29, 2023 |
| Redmond Asset Management, LLC | 3.71% | 579,980 | 806.17K | Jun 29, 2023 |
| Geode Capital Management, LLC | 1.32% | 206,754 | 287.39K | Jun 29, 2023 |
| Blackrock Inc. | 0.85% | 132,572 | 184.28K | Jun 29, 2023 |
| State Street Corporation | 0.57% | 88,659 | 123.24K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.63% | 566,688 | 787.70K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 1.92% | 300,650 | 417.90K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.69% | 107,562 | 128.00K | May 30, 2023 |
| iShares Micro Cap ETF | 0.34% | 53,550 | 27.26K | Aug 30, 2023 |
| Fidelity Total Market Index Fund | 0.26% | 40,821 | 48.58K | May 30, 2023 |
| Vanguard Balanced Index Fund | 0.21% | 32,261 | 44.84K | Jun 29, 2023 |